Alterations in the Synthesis of a Fibroblast Surface Associated 35 K Protein Modulates the Binding of Somatomedin-C/lnsulin-Like Growth Factor I*
Authors:
- Victor K. M. HanVHVictor K. M. Han
- Robert G. ElginRERobert G. Elgin
- A. Joseph D'ERcoleADA. Joseph D'ERcole
- 1 May 1987
- journal article
- research article
- Published by The Endocrine Society in Molecular Endocrinology
- Vol. 1 (5) , 339-347
Abstract
Human fibroblasts, a cell type that is used extensively to determine the pleiotypic effects of the insulin-like growth factors, have been shown to secrete a 35K protein that binds somatomedin-C/insulin-like growth factor I (Sm-C/IGF-I) but not insulin. This 35 K protein is associated with the fibroblast surface and following transfer to the surface of cell types that do not have this protein on their surfaces, it alters the binding of radiolabeled Sm-C/IGF-I. In this study human fibroblast monolayers that were incubated with cyclohexamide (50 micrograms/ml) for 14 h at 37 C had no detectable 35 K protein on their cell surface, but type I Sm-C/IGF-I receptors were still present. Loss of the 35 K protein was associated with 60-70% increase in binding of Sm-C/IGF-I to type I receptors. The relative affinity of the type I receptor for Sm-C/IGF-I was apparently increased because unlabeled Sm-C/IGF-I (12 ng/ml) competitively displaced 63% of radiolabeled Sm-C/IGF-I after cycloheximide exposure, whereas in cultures not exposed to cycloheximide [125I]Sm-C/IGF-I binding was increased by 11%. Coincubation of fibroblast conditioned media containing the 35 K protein with cycloheximide-treated fibroblast monolayers resulted in restoration of the paradoxical increase in Sm-C/IGF-I binding and loss of sensitivity to competition by unlabeled Sm-C/IGF-I. Exposure of suspended fibroblasts, which do not have 35 K on their cell surface, to media conditioned by fibroblast monolayers also induced both of these changes.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 24 references indexed in Scilit:
- EVIDENCE FOR PRODUCTION BY THE LIVER OF TWO IGF BINDING PROTEINS WITH SIMILAR MOLECULAR WEIGHTS BUT DIFFERENT AFFINITIES FOR IGF I AND IGF II. THEIR RELATIONS WITH SERUM AND CEREBROSPINAL FLUID IGF BINDING PROTEINS.The Journal of Clinical Endocrinology & Metabolism, 1982
- Developmental Pattern of a Serum Binding Protein for Multiplication Stimulating Activity in the RatJournal of Clinical Investigation, 1982
- The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor.Journal of Biological Chemistry, 1982
- Structural similarities between human receptors for somatomedin C and insulin: analysis by affinity labelingBiochemistry, 1981
- Demonstration of two subtypes of insulin-like growth factor receptors by affinity cross-linking.Journal of Biological Chemistry, 1981
- Inhibition of biological activity of multiplication-stimulating activity by binding to its carrier protein.Proceedings of the National Academy of Sciences, 1980
- Effect of charge changes in ligand-triggered membrane cooperative transitionsJournal of Theoretical Biology, 1979
- PARTIAL PURIFICATION AND CHARACTERIZATION OF A BINDING PROTEIN FOR INSULIN-LIKE ACTIVITY (ILAs) IN HUMAN AMNIOTIC FLUID: A POSSIBLE INHIBITOR OF INSULIN-LIKE ACTIVITYEuropean Journal of Endocrinology, 1979
- Dual control of cell growth by somatomedins and platelet-derived growth factor.Proceedings of the National Academy of Sciences, 1979
- In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stainExperimental Cell Research, 1977